Your browser doesn't support javascript.
loading
A polygenic risk score for multiple myeloma risk prediction.
Canzian, Federico; Piredda, Chiara; Macauda, Angelica; Zawirska, Daria; Andersen, Niels Frost; Nagler, Arnon; Zaucha, Jan Maciej; Mazur, Grzegorz; Dumontet, Charles; Watek, Marzena; Jamroziak, Krzysztof; Sainz, Juan; Várkonyi, Judit; Butrym, Aleksandra; Beider, Katia; Abildgaard, Niels; Lesueur, Fabienne; Dudzinski, Marek; Vangsted, Annette Juul; Pelosini, Matteo; Subocz, Edyta; Petrini, Mario; Buda, Gabriele; Razny, Malgorzata; Gemignani, Federica; Marques, Herlander; Orciuolo, Enrico; Kadar, Katalin; Jurczyszyn, Artur; Druzd-Sitek, Agnieszka; Vogel, Ulla; Andersen, Vibeke; Reis, Rui Manuel; Suska, Anna; Avet-Loiseau, Hervé; Kruszewski, Marcin; Tomczak, Waldemar; Rymko, Marcin; Minvielle, Stephane; Campa, Daniele.
Afiliação
  • Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. f.canzian@dkfz.de.
  • Piredda C; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Macauda A; Department of Biology, University of Pisa, Pisa, Italy.
  • Zawirska D; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Andersen NF; Department of Biology, University of Pisa, Pisa, Italy.
  • Nagler A; Department of Hematology, University Hospital of Cracow, Cracow, Poland.
  • Zaucha JM; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Mazur G; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Dumontet C; Department of Hematology, Sea Hospital, Gdynia, Poland.
  • Watek M; Department of Internal and Occupational Diseases, Hypertension and Clinical Oncology, Medical University Wroclaw, Wroclaw, Poland.
  • Jamroziak K; Cancer Research Center of Lyon/Hospices Civils de Lyon, Lyon, France.
  • Sainz J; Hematology Clinic, Holycross Cancer Center, Kielce, Poland.
  • Várkonyi J; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Butrym A; Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada/Andalusian Regional Government, Granada, Spain.
  • Beider K; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.
  • Abildgaard N; Third Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Lesueur F; Department of Internal and Occupational Diseases, Medical University Wroclaw, Wroclaw, Poland.
  • Dudzinski M; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Vangsted AJ; Department of Hematology, Odense University Hospital, Odense, Denmark.
  • Pelosini M; Institut Curie, PSL Research University, Mines ParisTech Inserm, U900, Paris, France.
  • Subocz E; Hematology Department, Teaching Hospital No 1, Rzeszów, Poland.
  • Petrini M; Department of Hematology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
  • Buda G; Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
  • Razny M; Department of Haematology, Military Institute of Medicine, Warsaw, Poland.
  • Gemignani F; Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
  • Marques H; Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
  • Orciuolo E; Department of Hematology, Rydygier Specialistic Hospital, Cracow, Poland.
  • Kadar K; Department of Biology, University of Pisa, Pisa, Italy.
  • Jurczyszyn A; Life and Health Sciences Research Institute (ICVS), School of Health Sciences/Molecular Oncology Research Center, University of Minho, Braga, Portugal.
  • Druzd-Sitek A; Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
  • Vogel U; Third Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Andersen V; Department of Hematology, Jagiellonian University Medical College, Cracow, Poland.
  • Reis RM; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Suska A; National Research Centre for the Working Environment, DK-2100, Copenhagen, Denmark.
  • Avet-Loiseau H; Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
  • Kruszewski M; Life and Health Sciences Research Institute (ICVS), School of Health Sciences/Molecular Oncology Research Center, University of Minho, Braga, Portugal.
  • Tomczak W; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Rymko M; Molecular Oncology Research Center, Barretos Cancer Hospital, S.Paulo, Brazil.
  • Minvielle S; Department of Hematology, Jagiellonian University Medical College, Cracow, Poland.
  • Campa D; Unité de Génomique du Myélome, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France.
Eur J Hum Genet ; 30(4): 474-479, 2022 04.
Article em En | MEDLINE | ID: mdl-34845334
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estudo de Associação Genômica Ampla / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Hum Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estudo de Associação Genômica Ampla / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Hum Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido